Use of CSF-1 to treat bacterial infections
US5614183A · kind A · utility
0Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 1995 |
| Grant date | Mar 25, 1997 |
| Priority date | — |
| Expiry date | Jan 11, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.